Pharmacological Interventions for Adolescent Substance Use Disorders

Adolescent Substance Abuse: Psychiatric Comorbidity and High Risk Behaviors

Volumn , Issue , 2011, Pages 145-161

  Upadhyaya, Himanshu ^a   Deas, Deborah ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85077256128     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203843727-13     Document Type: Chapter

References (48)

1. Alterman, A. I., O’Brian, C. P., & McLellan, A. T. (1991). Differential therapeutics for substance abuse. In R. J. Frances & S. I. Miller (Eds.), Clinical textbook of addictive disorders (pp. 369-390). New York: Guilford Press.
2. Anton, R. F., Moak, D. H., & Latham, P. (1995). The Obsessive Compulsive Drinking Scale: A self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcoholism: Clinical and Experimental Research, 19, 92-99.
3. Brent, D., & Birmaher, B. (2004). British warnings on SSRIs questioned: Letter to the editor. Journal of the American Academy of Child and Adolescent Psychiatry, 43(4), 379-380.
4. Brown, S. A., & D’Amico, E. J. (2001). Outcomes of alcohol treatment for adolescent. Recent Developments in Alcoholism, 15, 307-327.
5. Bukstein, O. G., & Kithas, J. (2002). Pharmacological treatment of substance use disorders. In D. A. Rosenberg, P. A. Davanzo, & S. Gershon (Eds.), Pharmacotherapy for child and adolescent psychiatric disorders (2nd ed., pp. 679-710). New York: Marcel-Dekker.
6. Bukstein, O. G., & Tarter, R. (2005). Substance use disorders. In C. E. Coffey & R. A. Brumback (Eds.), Pediatric neuropsychiatry (pp. 321-341). Philadelphia: Lippincott Williams & Williams.
7. Clark, D. B., Wood, D. S., Cornelius, J. R., Bukstein, O. G., & Martin, C. S. (2003). Clinical practices in the pharmacological treatment of comorbid psychopathology in adolescents with alcohol use disorders. Journal of Substance Abuse Treatment, 25, 293-295.
8. Collins, E. D., & Kleber, H. D. (2004). Opioids: Detoxification. In M. Galanter & H. D. Kleber (Eds.), Textbook of substance abuse treatment (pp. 265-289). Washington, DC: American Psychiatric Press, Inc.
9. Dahchour, A., & De Witte, P. (2000). Ethanol and amino acids in the central nervous system: Assessment of the pharmacological actions of acamprosate. Progress in Neurobiology, 60(4), 343-362.
10. Dawes, M., & Johnson, B. A. (2004). Pharmacotherapeutic trials in adolescent alcohol use disorders: Opportunities and challenges. Alcohol and Alcoholism, 39(3), 166-177.
11. Deamer, R. L., Wilson, D. R., Clark, D. S., & Prichard, J. G. (2001). Torsades de pointes associated with high dose levomethadyl acetate (OR-LAAM). Journal of Addictive Disease, 20, 7-14.
12. DeAngelis, G., & Lehmann, W. (1973). Adolescents and short-term, low-dose methadone maintenance. The International Journal of the Addictions, 5(5), 853-863.
13. Deas, D., May, K., Randall, C., Johnson, N., & Anton, R. (2005). Naltrexone treatment of adolescent alcoholics: An open-label pilot study. Journal of Child and Adolescent Psychopharmacology, 15(5), 723-728.
14. Deas, D., Randell, C. L., Roberts, J. S., & Anton, R. F. (2000). A double-blind placebo-controlled trial of sertraline in depressed adolescent alcoholics: A pilot study. Human Psychopharmacology, 15, 461-469.
15. Deas, D., & Thomas, S. E. (2001). An overview of controlled studies of adolescent substance abuse treatment. The American Journal on Addictions, 10, 178-189.
16. Fiore, M. C., Bailey, W. C., Cohen, S. J., Dorfman, S. F., Goldstein, M. G., Gritz, E. R., et al. (2000). Treating tobacco use and dependence. Quick reference guide for clinicians. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service.
17. George, T. P., & O’Malley, S. S. (2004). Current pharmacological treatments for nicotine dependence. Trends in Pharmacological Sciences, 25(1), 42-48.
18. Grandhi, D., Jaffe, J., McNary, S., Kavanagh, G., Hayes, M., & Currens, M. (2003). Short-term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users. Addiction, 95(4), 453-462.
19. Hanson, K., Allen, S., Jensen, S., & Hatsukami, D. (2003). Treatment of adolescent smokers with the nicotine patch. Nicotine & Tobacco Research, 5, 515-526.
20. Hurt, R. D., Croghan, G. A., Beede, S. D., Wolter, T. D., Croghan, I. T., & Patten, C. A. (2000). Nicotine patch therapy in 101 adolescent smokers: Efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels. Archives of Pediatric and Adolescent Medicine, 154, 31-37.
21. Johnson, B., Roache, J., Javors, M., DiClemente, C., Cloninger, C., Prihoda, T., et al. (2001). Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized, controlled trial. JAMA, 284(8), 963-971.
22. Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2005). Monitoring the future national survey results on drug use, 1975-2004. Volume I: Secondary school students (NIH Publication No. 05-5727). Bethesda, MD: National Institute on Drug Abuse.
23. Kaminer, Y. (1994). Adolescent substance abuse. New York: Plenum Medical.
24. Kaminer, Y. (2001). Psychopharmacological therapy. In E. Wagner & H. Waldron (Eds.), Innovations in adolescent substance abuse interventions (pp. 285-311). Elmsford, NY: Pergamon.
25. Killen, J. D., Robinson, T. N., Ammerman, S., Hayward, C., Rogers, J., Stone, C., et al. (2004). Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. Journal of Consulting and Clinical Psychology, 72, 729-735.
26. Kranzler, H., Pierucci-Lagha, Feinn R., & Hernandez-Avilla, C. (2003). Effects of ondansetron in early- versus late-onset alcoholics: A prospective, open-label study. Alcoholism: Clinical and Experimental Research, 27(7), 1150-1155.
27. Lifrak, P. D., Alterman, A. I., O’Brian, C. P., & Volpicelli, J. R. (1997). Naltrexone for alcoholic adolescents. American Journal of Psychiatry, 154, 439-440.
28. Ling, W., Huber, A., & Rawson, R. A. (2001). New trends in opiate pharmacotherapy. Drug and Alcohol Review, 20, 79-94.
29. Marsch, L. A., Bickel, W. K., Badger, G. J., Stothart, M. E., Quesnal, K. J., Stanger, C., et al. (2005). Comparison of pharmacological treatments for opioid-dependent adolescents. Archives of General Psychiatry, 62, 1157-1164.
30. Mayo-Smith, M. F. (1997). Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA, 278, 144-151.
31. Moolchan, E. T., Robinson, M. L., Ernst, M., Cadet, J. L., Pickworth, W. B., Heishman, S. J., et al. (2004). Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics, 115, 407-414.
32. Myers, W. C., Donahue, J. E., & Goldstein, M. R. (1994). Disulfiram for alcohol use disorders in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 484-489.
33. Niedederhofer, H., & Staffen, W. (2003a). Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents. Drug and Alcohol Review, 22, 295-297.
34. Niedederhofer, H., & Staffen, W. (2003b). Acamprosate and its efficacy in treating alcohol-dependent adolescents. European Child & Adolescent Psychiatry, 12(3), 144-148.
35. O’Connor, P. G. (2005). Methods of detoxifiction and their role in treating patients with opioid dependence. JAMA, 294, 961-963.
36. Rankin, H., Hodgson, R., & Stockwell, T. (1979). The concept of craving and its measurement, Behaviour Research and Therapy, 17, 389-396.
37. Schottenfeld, R. S. (2004). Opioids: Maintenance treatment. In M. Galanter & H. D. Kleber (Eds.), Textbook of substance abuse treatment (pp. 291-304). Washington, DC: American Psychiatric Press, Inc.
38. Schuckit, M. A., & Tapert, S. (2004). Alcohol. In M. Galanter & H. D. Kleber (Eds.), Textbook of substance abuse treatment (pp. 151-166). Washington, DC: American Psychiatric Press, Inc.
39. Smith, T. A., House, R. F., Croghan, I. T., Gauvin, T. R., Colligan, R. C., Offord, K. P., et al. (1996). Nicotine patch therapy in adolescent smokers. Pediatrics, 98, 659-667.
40. Thomas, S. E., & Deas, D. (2005). The A-OCDS predicts craving and alcohol cue reactivity in adolescent alcoholics. Addictive Behaviors, 30, 1638-1648.
41. Thomas, S. E., Drobes, D. J., & Deas, D. (2005). Alcohol cue reactivity in alcohol-dependent adolescents. Journal of Studies on Alcohol, 66, 354-360.
42. Treatment for Adolescents with Depression Study. (2005). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. JAMA, 292, 807-820.
43. Upadhyaya, H. P., Brady, K. T., & Wang, W. (2004). Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: A pilot study. Journal of American Academy of Child and Adolescent Psychiatry, 43, 199-205.
44. Upadhyaya, H. P., Deas, D., & Brady, K. T. (2005). A practical clinical approach to the treatment of nicotine dependence in adolescents. Journal of American Academy of Child and Adolescent Psychiatry, 44, 942-946.
45. Upadhyaya, H. P., Deas, D., Brady, K. T., & Kruesi, M. (2002). Cigarette smoking and psychiatric comorbidity in children and adolescents. Journal of American Academy of Child and Adolescent Psychiatry, 41(11), 1294-1305.
46. Volpicelli, J. R., Alterman, A., Hayashida, M., & O’Brian, C. P. (1992). Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry, 49, 876-880.
47. Waxmonsky, J. G., & Wilens, T. E. (2005). Pharmacotherapy of adolescent substance use disorders: A review of the literature. Journal of Child and Adolescent Psychopharmacology, 15(5), 810-825.
48. Wold, M., & Kaminer, Y. (1997). Naltrexone for alcohol abuse. Journal of the American Academy for Child and Adolescent Psychiatry, 36, 6-7.